Histone deacetylases in kidney development: implications for disease and therapy.
about
Epigenetics of Renal Development and DiseaseTreatment of chronic kidney diseases with histone deacetylase inhibitors.Vorinostat protects against calcium oxalate-induced kidney injury in mice.HDAC inhibitors in kidney development and disease.Regulation of retinoic acid synthetic enzymes by WT1 and HDAC inhibitors in 293 cells.TGF-β induces miR-30d down-regulation and podocyte injury through Smad2/3 and HDAC3-associated transcriptional repression.Tissue-Specific Functions of p53 During Kidney Development.
P2860
Q28079434-BA86CD12-D73B-4A3D-BDE9-B0442123E852Q35545347-24284043-219F-41C8-B3E3-973D12480EFAQ35919757-D8B9E524-BD28-4763-B810-080BBEEFAE8EQ37115414-18A03FCA-18B9-4EDA-836D-69CACCCE7E11Q38698079-88326B4C-7954-498A-BEF9-1CCF24759280Q38830674-795CDB9A-C2DF-4397-A139-792F7F6D9F48Q39242429-A0B87B99-E1F8-4706-BDD0-9731B9D00246
P2860
Histone deacetylases in kidney development: implications for disease and therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Histone deacetylases in kidney development: implications for disease and therapy.
@en
type
label
Histone deacetylases in kidney development: implications for disease and therapy.
@en
prefLabel
Histone deacetylases in kidney development: implications for disease and therapy.
@en
P2860
P1433
P1476
Histone deacetylases in kidney development: implications for disease and therapy.
@en
P2093
Samir S El-Dahr
Shaowei Chen
P2860
P2888
P304
P356
10.1007/S00467-012-2223-8
P577
2012-06-22T00:00:00Z
P6179
1000716584